BOSTON, May 12, 2026 /PRNewswire/ -- GenScript Biotech Corporation announced the launch of TurboCHO™ Protein Expression Kit, a next-generation antibody expression reagent designed to set a new ...
We previously compared the expression of several human factor VIII (fVIII) transgene variants and demonstrated the superior expression properties of B domain-deleted porcine fVIII. Subsequently, a ...
Introducing the TurboCHO™ Protein Expression Kit, a launchpad in every kit. Producing research-grade antibodies and proteins is a foundational step in drug discovery and biologics development. The new ...
Producing research-grade antibodies and proteins is a foundational step in drug discovery and biologics development. The new kit brings GenScript's proven protein-expression technology directly to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results